Maria Piedad
Fernandez Perez

Foto de Maria Piedad

Foto de Hospital Universitario Reina Sofia

Hospital Universitario Reina Sofia

Córdoba, España

Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Reina Sofia (6)

2024

Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer
Cancers, Vol. 16, Núm. 14

2023

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide
Prostate, Vol. 83, Núm. 4, pp. 376-384

2022

Corrigendum to “589P Dynamics of peripheral blood immune profiling associated with tumour progression in metastatic castration resistant prostate cancer (mCRPC)”: [Annals of Oncology 32 suppl. 5 (2021) S637-S638] (Annals of Oncology (2021) 32 suppl. 5(S637-S638) (S0923753421033317), (10.1016/j.annonc.2021.08.1102))
Annals of Oncology

2021

Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients
Scientific Reports, Vol. 11, Núm. 1
miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis
Haematologica, Vol. 106, Núm. 6, pp. 1636-1646

2017

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study
Annals of Oncology, Vol. 28, Núm. 7, pp. 1-9